Genomic Profiling of a Phase III Clinical Trial of Interferon Versus Hydroxyurea in MPN Patients Reveals Mutation-Specific and Treatment-Specific Patterns of Response

Trine Alma Knudsen, Vibe Skov, Lillian Werner, William Duke, Christopher J. Gibson, Anwesha Nag, Aaron R. Thorner, Bruce Wollison, Dennis Lund Hansen, Thomas Stauffer Larsen, Christina Ellervik, Daniel El Fassi, Karin de Stricker, Lukas Frans Ocias, Mette Brabrand, Ole Weiss Bjerrum, Ulrik Malthe Overgaard, Mikael Frederiksen, Thomas Kielsgaard Kristensen, Torben A KruseMads Thomassen, Torben Mourits-Andersen, Marianne Tang Severinsen, Stentoft Jesper, Jørn Starklint, Peter Møller, Donna S. Neuberg, Lasse Kjær, Hans Carl Hasselbalch, R Coleman Lindsley, Ann Mullally

Publikation: Konferencebidrag uden forlag/tidsskriftPosterForskningpeer review

OriginalsprogEngelsk
Publikationsdato9. dec. 2019
StatusUdgivet - 9. dec. 2019
BegivenhedAmerican Society of Hematology: 61st Annual Meeting (ASH) - Orlando, USA
Varighed: 7. dec. 201910. dec. 2019

Konference

KonferenceAmerican Society of Hematology: 61st Annual Meeting (ASH)
LandUSA
ByOrlando
Periode07/12/201910/12/2019

Citationsformater

Knudsen, T. A., Skov, V., Werner, L., Duke, W., Gibson, C. J., Nag, A., Thorner, A. R., Wollison, B., Lund Hansen, D., Larsen, T. S., Ellervik, C., El Fassi, D., de Stricker, K., Ocias, L. F., Brabrand, M., Weiss Bjerrum, O., Overgaard, U. M., Frederiksen, M., Kielsgaard Kristensen, T., ... Mullally, A. (2019). Genomic Profiling of a Phase III Clinical Trial of Interferon Versus Hydroxyurea in MPN Patients Reveals Mutation-Specific and Treatment-Specific Patterns of Response. Poster session præsenteret på American Society of Hematology: 61st Annual Meeting (ASH), Orlando, USA.